Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – other biologic treatment
FRI0180 The musashi study: Comparison of subcutaneous tocilizumab monotherapy versus intravenous tocilizumab monotherapy: Results from a double-blind, parallel-group, comparative phase III non-inferiority study in japanese patients with rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.